Peterlin, P. and Jullien, M. (2025) “Response to Comment on: FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome/chronic myelomonocytic leukemia receiving CPX-351: a study from the Groupe Francophone des Myélodysplasies”, Haematologica. Pavia, Italy, 110(5), p. 1237. doi: 10.3324/haematol.2025.287378.